Supernus Pharmaceuticals (SUPN) Change in Account Payables (2014 - 2020)
Supernus Pharmaceuticals (SUPN) reported Change in Account Payables of $5.7 million for Q3 2020, up 564.92% year-over-year from $853037.5 in Q4 2019, and up 3216.48% quarter-over-quarter from -$182000.0 in Q2 2020.
Supernus Pharmaceuticals (SUPN) Change in Account Payables (2014 - 2020) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 7 years of Change in Account Payables data on file, last reported at $5.7 million in Q3 2020.
- Change in Account Payables for Q3 2020 came in at $5.7 million, up 564.92% year-over-year; the trailing twelve-month figure through Sep 2020 was $5.8 million (up 182.67% YoY), and the FY2019 annual result was $7.0 million, up 294.58% from the prior year.
- Change in Account Payables grew to $5.7 million in Q3 2020 per SUPN's latest filing, from -$182000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $7.3 million in Q4 2019 and troughed at -$7.0 million in Q1 2020.
- A 5-year average of $247736.8 and a median of -$380000.0 in 2016 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2017 and 2018: Change in Account Payables soared 937.63% in 2017, then plunged 1060.12% in 2018.
- A 5-year view of Change in Account Payables shows it stood at $5.1 million in 2016, then slumped by 86.43% to $692000.0 in 2017, then sank by 1060.12% to -$6.6 million in 2018, then surged by 209.81% to $7.3 million in 2019, then fell by 22.26% to $5.7 million in 2020.
- Business Quant data shows SUPN's Change in Account Payables at $5.7 million in Q3 2020, -$182000.0 in Q2 2020, and -$7.0 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 5.67 Mn |
| Sep 30, 2020 | 5.67 Mn |
| Jun 30, 2020 | -182,000.00 |
| Jun 30, 2020 | -182,000.00 |
| Mar 31, 2020 | -7.02 Mn |
| Mar 31, 2020 | -7.02 Mn |
| Dec 31, 2019 | 7.30 Mn |
| Dec 31, 2019 | 7.30 Mn |
| Sep 30, 2019 | -1.22 Mn |
| Sep 30, 2019 | -1.22 Mn |
| Jun 30, 2019 | -3.16 Mn |
| Jun 30, 2019 | -3.16 Mn |
| Mar 31, 2019 | 4.05 Mn |
| Mar 31, 2019 | 4.05 Mn |
| Dec 31, 2018 | -6.64 Mn |
| Dec 31, 2018 | -6.64 Mn |
| Sep 30, 2018 | 6.90 Mn |
| Sep 30, 2018 | 6.90 Mn |
| Jun 30, 2018 | -398,000.00 |
| Jun 30, 2018 | -398,000.00 |